Ventritex's P2P Acquisition

Ventritex raised a round of funding on October 24, 1996. Investors include St. Jude Medical.

Ventritex is marketed as a minimally invasive diagnostic system for mapping arrhythmias, potentially fatal or life debilitating heart rhythms.…

Articles about Ventritex's P2P Acquisition: